Medical Device

Leonhardt Ventures LLC is pleased to announce the issuance of U.S. Leonhardt et. al. Patent 12,109,410 with 15 claims entitled “Bioelectric Stimulator”, a significant advancement in the field of regenerative medicine.

At the DFCon Conference Symposium in Los Angeles, Anderson Medical Supplies, AlexiGen, Defender and Sensoria Health Inc. announced that they are joining forces on a groundbreaking partnership aimed at delivering the Alternative to Amputation: Footwear as a Service (FAAS): A Remote Patient Monitoring Artificial Intelligence Platform.

Lionheart Health announced today additions to its board of directors and executive leadership team including Scott Hoots as co-CEO, Tessa Sphar as Onboarding Specialist for Licensees, Dr. Jwala Karnik to our Board of Directors and Chad Hacker to both Board of Directors and to our Marketing Team.

Nearly 1% of the world’s population is at risk of suffering essential tremor, equating to more than 70 million people worldwide.

Phase 1 consisted of 21 participants (n=21) both male and female over a wide age group. At the beginning of the study, the participants completed the PTSD checklist PCL-5 which is widely used by the Veterans Administration (VA) for testing the effectiveness of various interventions.

New Patented Technology Increases Klotho Levels up to 150%. The BodStim wearable bioelectric bodysuit has been FDA-cleared, after proving its ability to augment exercise to previously undiscovered levels: signaling sequences that control the release of Klotho.

A retired space shuttle Chief Engineer has resurrected an almost-forgotten healing therapy from the early 20th century and re-engineered it for consumer use. Mark Fox, a chemical engineer, inventor, and retired rocket scientist, is the brains behind the new device. Fox shrank the logic and circuitry of Nikolai Tesla’s “electrotherapy device” and packaged it in a pocket-sized container that looks just like an 80’s music cassette tape.

One hundred participants suffering from PTSD or trauma are sought for in-home clinical study for its Resonance Frequency Therapy™ device. This study will examine the effectiveness of a drug-free device.